FDA advisory panel recommends darbepoetin alpha remain on market - Cardiology Today PDF Print
Cardiology TodayThe Cardiovascular and Renal Drugs Advisory Committee voted 15 to 1 to recommend keeping darbepoetin on the market, despite an increased risk for stroke

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.